Annette von Drygalski
28PUBLICATIONS
74CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (28)
Sort by Publication Date:
|Apr 06, 2025
Completion of phase 2b trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B over 5 years.Annette von Drygalski, Esteban Gomez, Adam Giermasz
|Oct 03, 2024
Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort.Jacqueline N Poston, Cassandra Bryan, Annette von Drygalski
|Aug 01, 2024
Evaluating the impact of a year-long external mentorship pilot program in classical hematology.Zoya Qureshy, Pooja Nair, Sara K Vesely
|Jun 06, 2024
Optimizing liver health before and after gene therapy for hemophilia A.Margaret V Ragni, Henry Mead, Ype P de Jong
|Dec 12, 2023
The current challenges faced by people with hemophilia B.Wolfgang Miesbach, Annette von Drygalski, Clive Smith
|Nov 14, 2023
Etranacogene dezaparvovec-drlb gene therapy for patients with hemophilia B (congenital factor IX deficiency).Tro Sekayan, Dana H Simmons, Annette von Drygalski
Pageof 5
Frequent Collaborators
7 joint publications
Richard F W Barnes
2 joint publications
Eric Y Chang
2 joint publications
Dana H Simmons
2 joint publications
Saunya Dover
2 joint publications
Miguel A Escobar
2 joint publications
Srila Gopal
1 joint publications
R A Gruppo
1 joint publications
Bilgimol Chumappumkal Joseph
1 joint publications
Danial M Ignas
1 joint publications
Kathelijn Fischer
